The future of alzheimer disease immunotherapies in Saudi Arabia: Consensus statement of the Saudi Chapter of Cognitive and Behavioral Neurology.

导出 OA

翻译打印收藏纠错

作者： Haythum O,Tayeb ^[1] ; Roaa A,Khallaf ^[1] ; Taim A,Muayqil ^[1] ; Walid A,Alkeridy ^[1] ; Fawwaz S,Alibrahim ^[1] ; Omar A,Alfaify ^[1] ; Najeeb,Qadi ^[1] ; Frank I,Tarazi ^[1]

作者单位： From The Neuroscience Research Unit and the Mind and Brain Studies Initiative (Tayeb), Division of Neurology, Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, from the Department of neurology (Khallaf), Neuroscience Center, King Fahad Specialist Hospital Dammam, from Neurology Unit (Muayqil), from the the Department of Medicine (Alkeridy), College of Medicine, King Saud University, Riyadh, from the Neurology Division (Alibrahim), Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, from the Department of Neurology (Alfaify), Prince Sultan Military Medical City, from the Neuroscience Centre (Qadi), King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, and from the Department of Psychiatry and Neuroscience (Tarazi), Harvard Medical School and McLean Hospital, Belmont, USA. ^[1]

主题词人类(Humans);阿尔茨海默病(Alzheimer Disease);沙特阿拉伯(Saudi Arabia);免疫疗法(Immunotherapy);神经病学(Neurology);认知(Cognition)

DOI 10.17712/nsj.2023.2.20220133

PMID 37045461

发布时间 2023-05-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交